相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
Shirley Yin-Yu Pang et al.
TRANSLATIONAL NEURODEGENERATION (2022)
Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson's Disease Patient Monocytes and Inversely Correlates with Motor Severity
Laura P. Hughes et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
Samantha M. Carlisle et al.
NPJ PARKINSONS DISEASE (2021)
Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases
Prakash Babu Narasimhan et al.
JOURNAL OF IMMUNOLOGY (2020)
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease
Ruwani S. Wijeyekoon et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition
Anwesha Sanyal et al.
MOVEMENT DISORDERS (2020)
LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's
Rebecca L. Wallings et al.
FRONTIERS IN NEUROSCIENCE (2020)
LRRK2: Autophagy and Lysosomal Activity
Marta Madureira et al.
FRONTIERS IN NEUROSCIENCE (2020)
LRRK2 Is Recruited to Phagosomes and Co-recruits RAB8 and RAB10 in Human Pluripotent Stem Cell-Derived Macrophages
Heyne Lee et al.
STEM CELL REPORTS (2020)
Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions
Julia Obergasteiger et al.
CELL DEATH DISCOVERY (2020)
LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes
Zhiyong Liu et al.
EMBO JOURNAL (2020)
LRRK2 mediates tubulation and vesicle sorting from lysosomes
Luis Bonet-Ponce et al.
SCIENCE ADVANCES (2020)
LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
Rebecca Wallings et al.
HUMAN MOLECULAR GENETICS (2019)
Alterations in Blood Monocyte Functions in Parkinson's Disease
Sara Konstantin Nissen et al.
MOVEMENT DISORDERS (2019)
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Immune system responses in Parkinson's disease: Early and dynamic
Malu G. Tansey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
Farzaneh Atashrazm et al.
MOVEMENT DISORDERS (2019)
Immunometabolism: A Multi-Omics Approach to Interpreting the Influence of Exercise and Diet on the Immune System
David C. Nieman et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 10 (2019)
Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis
Rebecca L. Wallings et al.
TRENDS IN NEUROSCIENCES (2019)
LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients
Daniel Ysselstein et al.
NATURE COMMUNICATIONS (2019)
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Elena Kozina et al.
BRAIN (2018)
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
Farzaneh Atashrazm et al.
SCIENTIFIC REPORTS (2018)
Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus
Cornelis Blauwendraat et al.
MOVEMENT DISORDERS (2018)
Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women
Sara F. Milrad et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
Martin Steger et al.
ELIFE (2017)
LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model
Hien Tran Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells
Kenneth Thirstrup et al.
SCIENTIFIC REPORTS (2017)
LRRK2 levels in immune cells are increased in Parkinson'sdisease
D. A. Cook et al.
NPJ PARKINSONS DISEASE (2017)
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
Dena G. Hernandez et al.
JOURNAL OF NEUROCHEMISTRY (2016)
LRRK2 at the interface of autophagosomes, endosomes and lysosomes
Dorien A. Roosen et al.
MOLECULAR NEURODEGENERATION (2016)
Stress-induced neuroinflammatory priming is time of day dependent
Laura K. Fonken et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease A Systematic Review and Meta-analysis
Xiao-Yan Qin et al.
JAMA NEUROLOGY (2016)
Dopaminergic Receptors on CD4+T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease
Natasa Kustrimovic et al.
SCIENTIFIC REPORTS (2016)
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression
Anastasia G. Henry et al.
HUMAN MOLECULAR GENETICS (2015)
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinc Dursun et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
INFLAMMATION IS GENETICALLY IMPLICATED IN PARKINSON'S DISEASE
N. Dzamko et al.
NEUROSCIENCE (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Interferon- induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages
Martin Kuss et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Improved Quenched Fluorescent Probe for Imaging of Cysteine Cathepsin Activity
Martijn Verdoes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
LRRK2 as a modulator of lysosomal calcium homeostasis with downstream effects on autophagy
Patricia Gomez-Suaga et al.
AUTOPHAGY (2012)
Inflammatory cytokines and NT-proCNP in Parkinson's disease patients
Dariusz Koziorowski et al.
CYTOKINE (2012)
Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells
Bei Xiang et al.
BRAIN RESEARCH (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
Jonathan Thevenet et al.
PLOS ONE (2011)
Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research
Xin Zhou et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2010)
Specialized roles for cysteine cathepsins in health and disease
Jochen Reiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane
Di Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
LRRK2 Exon 41 mutations in sporadic Parkinson disease in Europeans
Suzanne Lesage et al.
ARCHIVES OF NEUROLOGY (2007)
Prevalence and incidence of Parkinson's disease in Europe
S von Campenhausen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)